Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
about
Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.Population-Based Pharmacokinetic Modeling of Vancomycin in Children with Renal InsufficiencyPrediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulationCurrent recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.Population pharmacokinetic studies in pediatrics: issues in design and analysis.Improved vancomycin dosing in children using area under the curve exposure.Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.Optimizing pediatric dosing: a developmental pharmacologic approach.Vancomycin: a review of population pharmacokinetic analyses.Vancomycin AUC/MIC and Corresponding Troughs in a Pediatric Population.Vancomycin and gentamicin pharmacokinetic alterations in an adolescent amputee.Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia.Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.Vancomycin dosing in children and young adults: back to the drawing board.Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
P2860
Q33797950-D7192FBE-B413-4991-AF26-CFC498560829Q34314798-C98BAAF6-FDB5-4711-8CC4-862854A86E6BQ34989352-4269833C-8E83-44F2-A614-7199CC31339CQ35004264-3096D6AA-D0D3-41E6-A2E9-EBA3FFDB88B5Q36341632-319D0734-4AAA-47A0-AA91-1F8D9C08010BQ36784672-CCE52A2B-F907-4226-BD94-1B7328F736BCQ37055102-84D681F7-9110-4B63-A10E-E83D35069AB9Q37498862-EDF803AC-B0CC-4BC6-9AFA-A9F0C6DCABC1Q37965578-AB13723A-2DA9-4510-B985-EAA937B466B0Q39197603-88A54C7D-0676-426B-A44A-DFD85F0D52C3Q39839904-048AF7C9-4DA1-47E0-BB40-AD56F77A3F4DQ43842726-80464273-7BC5-41B1-837B-D163E6F1D39FQ43984406-7E3416B3-7CFA-4096-AE0B-B9DC301372B9Q45329118-F074F6F6-993D-4199-8BBD-A0BA4FD89247Q51165832-E1B21D48-3DC7-4D7C-B62C-C74BEC53474EQ55136102-F345F0E1-3814-46CE-AAFD-42D9D942FC0EQ58699337-201AC15F-6672-4A04-B00C-B42E97919ECE
P2860
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
@en
type
label
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
@en
prefLabel
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
@en
P2093
P1476
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
@en
P2093
P304
P356
10.1097/00007691-200010000-00004
P577
2000-10-01T00:00:00Z